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Chikungunya fever, caused by the mosquito-borne
alphavirus Chikungunya virus, is endemic to Africa
and Southeast Asia. A seroprevalence study conducted
in Taiwan approximately 40 years ago found a preva-
lence rate of 90% among people aged over 40 years
[1]. Subsequently, however, the disease was not diag-
nosed in Taiwan until 2006, when all imported cases
of Chikungunya virus infection were detected at air-
ports in Taiwan [2]. Thus clinicians in Taiwan are un-
likely to have experience of this infectious disease,
which will probably lead to misdiagnosis and outbreak.
Therefore, there is a concern that Chikungunya fever
may reemerge as a public health threat in Taiwan.
Aedes albopictus is found throughout Taiwan while
Aedes aegypti is mainly found in Southern Taiwan.
Both vectors can transmit dengue and Chikungunya
viruses. According to the Taiwan Centers for Disease
Control data, the first two imported cases of Chikun-
gunya fever were identified by fever screening sen-
tinel systems at Taiwan airports [2]. Because of the
increasing prevalence of international travel, the wide
distribution of the competent vectors A. albopictus and
A. aegypti, and recent climate changes, it is possible
that concurrent increases in dengue and Chikun-
gunya may be seen in Taiwan, as is the case in many
African and Southeast Asian countries [3]. Here, we
report the clinical manifestations of a patient with
Chikungunya fever that developed immediately on
return from Malaysia. To the best of our knowledge,
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Chikungunya virus, a mosquito-borne alphavirus, is endemic in Africa and Southeast Asia but is
rarely reported in Taiwan. We report the case of a Taiwanese woman who developed Chikungunya
fever, which was first diagnosed by a clinician rather than by fever screening at an airport. The
woman presented with fever, maculopapular rash, and arthralgia, the triad for the disease, on the
day she returned home after a trip to Malaysia. These symptoms are very similar to those of
dengue fever, which is endemic in Southern Taiwan. Chikungunya infection was confirmed by
reverse transcriptase-polymerase chain reaction and seroconversion on paired serum specimens.
For approximately 40 years until 2006, no cases of Chikungunya fever had been found in Taiwan.
Clinicians in Taiwan should consider Chikungunya fever as a possible diagnosis for a febrile patient
with arthralgia, rash, and a history of travel to an endemic area, such as Africa or Southeast Asia.
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this is the first report of a case with Chikungunya fe-
ver to be diagnosed by a physician in Taiwan, rather
than by airport screening, for almost 40 years. This
report should raise awareness of this disease among
clinicians without experience of imported or indige-
nous Chikungunya fever.
CASE PRESENTATION
A 40-year-old woman was well before traveling to
Malaysia between January 22 and January 30, 2009.
Fever was noticed on the day she returned. Associated
symptoms were chills, cough with whitish sputum,
dyspnea, sore throat, headache, neck soreness, and
bilateral arthralgia over her knees, wrists, and ankles.
She had difficulty in walking, a rash appeared on the
skin of her back and she had bilateral conjunctivitis.
She denied any recent history of an insect bite or ani-
mal contact. She was admitted after presentation at
the hospital emergency room.
On admission, her blood pressure was 110/
55 mmHg with a heart rate of 97 beats/min, a respi-
ratory rate of 20 breaths/min and a temperature of
38.2°C. Physical examination revealed a rash over the
back of her torso, bilateral conjunctivitis, and bilat-
eral tenderness over her ankles and knees. Her labo-
ratory tests revealed mild anemia with a hemoglobin
level of 13 g/dL and a hematocrit of 39.3%. Her plate-
let count was 139 × 109/L, and her white blood cell
count was  4.07 × 109/L, with 85.5% neutrophils, 9.6%
lymphocytes, 4.7% monocytes and 0.2% basophils.
The prothrombin time was 10.9 seconds (control, 10.8
seconds) and the activated partial thrombin time was
prolonged at 31.7 seconds (control, 28.3 seconds).
Blood biochemistry showed normal renal function
and normal levels of aspartate aminotransferase
20 U/L (normal, 5–40 U/L), and alanine aminotrans-
ferase 12 U/L (normal, 5–55 U/L). Her electrolytes
were within normal limits (sodium, 135 mmol/L; 
potassium, 3.6 mmol/L). Chest X-ray showed no ab-
normal finding. Blood bacterial culture results were
negative.
Bronchitis, influenza, dengue fever, and Chikun-
gunya fever were the initial suspects. Doxycycline was
used as an empirical antibiotic. The high fever per-
sisted for 3 days. Follow-up laboratory data showed
a white blood cell count of 1.38 × 109/L and a platelet
count of 111 × 109/L. She had persistent joint pain.
She was discharged without fever after a 4-day 
hospitalization. A Chikungunya serological survey
obtained at initial presentation for fever revealed no
detectable immunoglobulin (Ig) G or IgM antibodies
to Chikungunya antigens based on enzyme-linked
immunosorbent assay methods, but a positive result
was obtained with reverse transcriptase-polymerase
chain reaction by the reference laboratory of the
Taiwan Centers for Disease Control [2]. A second
serological survey obtained 14 days later was positive
for IgG and IgM. After discharge, the mild bilateral
ankle pain persisted for 30 days.
DISCUSSION
Here, we have reported a case of imported Chikun-
gunya fever in Southern Taiwan, a tropical area, to
document the possibility of Chikungunya virus being
introduced by international travel into an area where
there are competent mosquito vectors. There was a
high prevalence rate (90%) for Chikungunya virus
among people aged over 40 years old in Taiwan 
40 years ago. However, the low prevalence rate (< 5%)
among people < 40 years old at that time suggested a
positive effect associated with mosquito control as
part of malaria eradication, although there was no
evidence for a cause-effect relationship [1]. No indi-
genous cases of Chikungunya fever have since been
reported, and there were no reports of imported cases
until fever surveillance at airports detected some cases
in 2006 [2]. Using the epidemiology of dengue and
Chikungunya in Singapore as an example, dengue
fever has been endemic in Singapore since the 1960s,
but the first Chikungunya case was only reported in
2006 [4]. In Taiwan, there was a 37-year period with-
out an endogenous case of dengue until the dengue-2
virus outbreak in 1987 [5]. Dengue fever, which is
transmitted by the same vectors as Chikungunya 
(A. albopictus and A. aegypti), has reemerged in the last
decade and has become endemic in Southern Taiwan.
Collectively, these findings suggest there is a high
risk for reemergence of Chikungunya fever in Taiwan
because of the existence of suitable vectors. The Italian
experience of an endemic outbreak of Chikungunya
fever provides another example of how developed or
developing countries with suitable weather for vec-
tors may experience outbreaks once the disease has
been imported unnoticed [6].
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Early diagnosis of Chikungunya fever is difficult
because its manifestations resemble those of other
tropical diseases, particularly dengue fever (Table) [7–
10]. Thus Chikungunya might be under diagnosed or
misdiagnosed as dengue in Taiwan. Arthritis and
arthralgia associated with Chikungunya can be quite
painful and usually involve small and large joints.
Intense pain elicited by pressure on the wrist is con-
sidered to be strongly suggestive of Chikungunya
[6,7]. Fever usually resolves within 3–7 days, but ar-
thralgia can persist for weeks after onset [8]. A gener-
alized maculopapular skin rash and conjunctivitis
occur in approximately half of all cases on Day 2–5 of
illness [11]. Another characteristic laboratory finding
at admission is lymphopenia (79%). Thrombocytope-
nia, a typical finding for dengue fever, is not promi-
nent in Chikungunya infection. In contrast, classic
dengue fever is an acute febrile illness that is accom-
panied by headache, retro-orbital pain, and marked
muscle and joint pains, the source of the term “break-
bone fever” [12]. Dengue fever typically lasts for 5–7
days [9]. Hemorrhagic manifestations are common 
in patients with dengue fever, but are only present in
6.4% of cases with Chikungunya [13]. Dengue fever
and dengue hemorrhagic fever typically result in
marked leukopenia and thrombocytopenia, in con-
trast to Chikungunya fever. In addition, dengue fever
is associated with prolonged suppression of leuko-
cyte and platelet counts, and plasma activated partial
thrombin time. Serum aspartate aminotransferase and
alanine aminotransferase levels are also frequently
elevated in patients with dengue fever [10]. In Chi-
kungunya fever, normal aspartate aminotransferase
and alanine aminotransferase levels are often found
with mild prolongation of activated partial thrombin
time. Our patient had bilateral tenderness over the
ankles and fever; notably, she also had recently trav-
elled to Malaysia. Her fever subsided in 3 days 
and only mild thrombocytopenia was found during
admission. A rash was detected on the first day after
the onset of fever. Therefore, dengue fever was con-
sidered less likely and our tentative diagnosis was
Chikungunya fever, which was later confirmed by
serologic and molecular tests.
After approximately 40 years without a confirmed
Chikungunya case, the first imported case of Chi-
kungunya fever was detected at Taiwan Taoyuan In-
ternational Airport in November 2006 [2]. Between
October 2007 and May 2009, 14 imported cases were
confirmed in Taiwan. The Chikungunya cases in 
2007 and 2008 originated from Indonesia, Malaysia,
Singapore, India and Bangladesh [2,14]. The distribu-
tion of imported Chikungunya cases was island-
wide. A limited awareness of Chikungunya fever by
Taiwan clinicians is anticipated because there have
been no endogenous cases for approximately 40 years,
and no imported cases were found until 2006. There-
fore, further education and experience sharing about
the diagnosis and treatment of Chikungunya fever
should be performed for clinicians throughout Taiwan.
Table. Comparison of clinical characteristics between dengue fever and Chikungunya fever
Dengue fever Chikungunya fever
Etiology Dengue virus Chikungunya virus
Main vectors Aedes aegypti Aedes aegypti
Aedes albopictus Aedes albopictus
Incubation period (d) 3–14 2–12
Endemic area Southeast Asia, endogenous cases Southeast Asia, Africa, only 
reported in Southern Taiwan imported cases in Taiwan
Clinical symptoms Fever, severe bone pain, Fever, headache, muscle pain, joint pain at the 
retrobulbar pain, headache, finger/toe/wrist/ankle, with arthralgia 
muscle pain, joint pain; persisting for weeks or months [7,8,10];
Common hemorrhagic manifestations; Rare hemorrhagic manifestations (6.4%) [10];
Rash onset after 3–5 days of fever; Early rash onset early;
Fever for 7 days [9] Fevers usually resolve within 3–7 days
Laboratory data AST and ALT usually increase AST and ALT usually increase by 1.5–2-fold; 
by 2–5-fold; marked thrombocytopenia mild thrombocytopenia and leukopenia with 
and leukopenia, initial neutrophilia initial lymphopenia, and hypocalcemia [10]
AST = Aspartate aminotransferase; ALT = alanine aminotransferase.
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The differential diagnosis of many tropical dis-
eases by clinical characteristics can be difficult be-
cause they share common features, including fever,
rash and arthralgia, with different degrees of sever-
ity. Clinicians should be vigilant for febrile patients
who are recent travelers from Chikungunya endemic
areas and who present with the triad of fever, rash
and arthralgia. In addition, public health officials
should watch for local transmission of Chikungunya
virus because it may be introduced into Taiwan by
travelers with viremia and then transmitted by local
mosquito vectors.
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屈公熱病毒是一種以蚊子為媒介的病毒，在非洲與東南亞有地區性的流行但在台灣很
少見。我們報告一台灣女病患在馬來西亞旅遊後回國當天有發燒、皮疹與多發性關節
炎之典型屈公熱症狀，這些症狀和南台灣地區性流行之登革熱症狀相似。經反轉錄聚
合酶反應與血清學檢驗證實為屈公熱。這是非經機場發燒篩檢而由醫師診斷之病例。
台灣在經過約 40 年沒有屈公熱病例報告後，於 2006 年在機場發燒篩檢開始陸續發現
少數境外移入個案。本報告之個案是台灣 40 年來第一位通過機場發燒篩檢而由臨床
醫師主動發現，也因此台灣醫師對於發燒病患合 關節痛、皮疹，並曾至屈公熱病毒流
行區旅遊者，需將屈公熱列入鑑別診斷。
關鍵詞：屈公熱，登革熱，台灣
（高雄醫誌 2010;26:256–60）
